In-vitro Colorectal Cancer Screening Tests Market Research Report, Trends, Demand, Key Player Analysis and Forecast 2023-2028

How Big is the In-vitro Colorectal Cancer Screening Tests Market ? :

IMARC Group's latest report, titled "In-vitro Colorectal Cancer Screening Tests Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", the global in-vitro colorectal cancer screening tests market size reached US$ 943 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,352 Million by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.

What is In-vitro Colorectal Cancer Screening Tests ? :

In-vitro colorectal cancer screening tests refer to diagnostic procedures that are performed outside the human body to detect the presence of colorectal cancer. These tests involve the use of cameras that capture images of the digestive tract and transfers them to the recorder tied to the waist of the patient. These tests are valuable tools for early detection because they are convenient, cost-effective, and have proven to be highly accurate in identifying individuals at risk. They can help save lives by enabling early intervention and timely treatment, ultimately improving the prognosis for colorectal cancer patients. As a result, in-vitro colorectal cancer screening tests are widely performed across clinics, hospitals, and diagnostics laboratories.

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/in-vitro-colorectal-cancer-screening-tests-market/requestsample

Who are the key Players Operating in the Industry ? :

• Beckman Coulter Inc. (Danaher Corporation)
• Eiken Chemical Co. Ltd
• Epigenomics AG
• Exact Sciences Corporation, Hemosure Inc
• Immunostics Inc. (Boditech Med Inc.)
• Medline Industries LP
• Merck KGaA
• Qiagen N.V
• Quest Diagnostics Incorporated
• R-Biopharm AG
• Siemens AG
• Sysmex Corporation

What are the Growth Prospects and Trends in the In-vitro Colorectal Cancer Screening Tests Industry ? :

The rising incidences of colorectal cancer (CRC) among the masses are driving the global market. Moreover, the growing awareness among healthcare providers and individuals about the importance of early detection and prevention of colorectal cancer is catalyzing the growth of the market. Besides, the integration of artificial intelligence and machine learning algorithms improves the performance and reliability of in-vitro colorectal cancer screening tests, thus propelling the market. Furthermore, the implementation of favorable government initiatives mandating cancer screening tests is positively influencing the market. Other factors, including extensive investments in research and development (R&D) activities, and improving healthcare infrastructure, are creating a positive market outlook.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/in-vitro-colorectal-cancer-screening-tests-market

What is Included in Market Segmentation ? :

The report has segmented the market into the following categories:

Breakup by Product:

• Fecal Occult Blood Tests
1. Guaiac FOB Stool Test
2. Immuno-FOB Agglutination Test
3. Lateral Flow Immuno-FOB Test
4. Immuno-FOB ELISA Test
• Biomarker Tests
1. Tumor M2-PK Stool Test
2. Transferrin Assays
• CRC DNA Screening Tests
1. Methylated Gene Testing
2. Panel DNA Tests

Breakup by Imaging Type:

• Colonoscopy
• Proctoscopy
• CT Scan
• Ultrasound
• MRI
• PET Scan

Breakup by End User:

• Hospitals
• Clinics
• Diagnostic Laboratories
• Others

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Related Report By IMARC Group:

• https://www.einpresswire.com/article/602996221/india-mushroom-market-to-grow-at-cagr-of-7-6-during-2023-2028

• https://www.einpresswire.com/article/603003086/india-drones-market-to-grow-at-cagr-of-10-23-during-2023-2028

• https://www.einpresswire.com/article/603005986/india-extended-warranty-market-to-grow-at-cagr-of-11-65-during-2023-2028

• https://www.einnews.com/pr_news/615622758/application-processor-market-global-industry-analysis-and-forecast-by-2023-2028

• https://www.einpresswire.com/article/625071036/3d-display-market-is-set-for-strong-growth-cagr-of-17-3-and-reach-around-us-365-6-billion-by-2028

Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.